Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia.

Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia on Physical Activity, Quality of Life and Immunoneuroendocrine Response.

The purpose of this study is to evaluate differences in neuroimmunoendocrine response and quality of live in patients diagnosed with Fibromyalgia, with or without a co-diagnosis of Chronic Fatigue Syndrome.

The limited literature published in concordant relation affects the chronic fatigue syndrome comorbidity in the daily life of fibromyalgia patients leads us to design this study with the main objective of evaluating differences in the quality of life associated with pain and stress, mainly in relation to levels of physical activity, sedentary lifestyle and sleep in patients diagnosed with fibromyalgia, with or without a parallel co-diagnosis of chronic fatigue syndrome.

Inclusion Criteria:

• Fibromyalgia and/or Chronic Fatigue Syndrome diagnosis by rheumatologists or internal medicine professionals.
• Age not less than 40 years old and not more than 65 years old.

Exclusion Criteria:

• Suffering from diagnosed "major depression".
• Suffer diagnosed multiple chemical sensitivity.
• Corticosteroid treatment or anti-cytokine therapies.
• Periodically carry out programmed therapeutic physical activity in the two months prior to the accelerometry tests.